Increased Risk for Non-Hodgkin Lymphoma in Individuals With Celiac Disease and a Potential Familial Association

被引:61
作者
Gao, Ying [1 ]
Kristinsson, Sigurdur Y. [2 ]
Goldin, Lynn R.
Bjorkholm, Magnus [2 ]
Caporaso, Neil E.
Landgren, Ola [2 ]
机构
[1] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[2] Karolinske Univ, Hosp Solna & Inst, Div Hematol, Dept Med, Stockholm, Sweden
关键词
POPULATION-BASED COHORT; DERMATITIS-HERPETIFORMIS; MALIGNANCY; MORTALITY; DIAGNOSIS; CANCER; SUSCEPTIBILITY; AUTOIMMUNITY; MULTICENTER; CHILDHOOD;
D O I
10.1053/j.gastro.2008.09.031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Celiac disease (CD), a common digestive disease, is well known to be associated with excess non-Hodgkin lymphoma (NHL) risk. However, there are only limited data on risk in the current era of serologic testing and human leukocytes antigen typing to screen for CD. There is also no information on the role of family history of CD in relation to lymphoma risk. Methods: We identified 37,869 NHL, 8323 Hodgkin lymphoma (HL), and 13,842 chronic lymphocytic leukemia patients diagnosed in Sweden between 1965 and 2004, as well as 236,408 matched controls and 613,961 first-degree relatives. Using logistic regression, we calculated odds ratios and 95% confidence intervals as measures of risks adjusted for matching factors. Results: Overall we found persons with a hospital discharge diagnosis of CD to have a 5.35-fold (95% CI, 3.56-8.06) increased NHL risk. Risk of HL was borderline increased (OR = 2.54, 95% CI, 0.99-6.56); however, there was no excess chronic lymphocytic leukemia risk. Persons diagnosed with CD in 1975-1984, 1985-1994, and 1995-2004 had a 13.2-fold (95% CI, 3.63- 48.0), 7.90-fold (95% CI, 3.38-18.5), and 3.84-fold (95% Cl, 2.28-6.45) increased risk of NHL, respectively (P-trend < .0001). individuals with a sibling affected with CD had a 2.03-fold (95% CI, 1.29-3.19) increased NHL risk. Conclusions: Persons with CD have an increased NHL risk; however, the excess risk has tapered off substantially in the last 4 decades. The observed excess NHL risk among individuals with a sibling affected with CD suggests shared susceptibility. Future studies are needed to explore the roles of gluten intake, secondary intestinal inflammation, and susceptibility genes in relation to subsequent risk of developing lymphoma.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 47 条
[1]   Malignancy and mortality in a population-based cohort of patients with coeliac disease or 'gluten sensitivity' [J].
Anderson, L. A. ;
McMillan, S. A. ;
Watson, R. G. P. ;
Monaghan, P. ;
Gavin, A. T. ;
Fox, C. ;
Murray, L. J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) :146-151
[3]   Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis [J].
Askling, J ;
Linet, M ;
Gridley, G ;
Halstensen, TS ;
Ekström, K ;
Ekbom, A .
GASTROENTEROLOGY, 2002, 123 (05) :1428-1435
[4]   Serologic and genetic markers of celiac disease: A sequential study in the screening of first degree relatives [J].
Bonamico, M ;
Ferri, M ;
Mariani, P ;
Nenna, R ;
Thanasi, E ;
Luparia, RPL ;
Picarelli, A ;
Magliocca, FM ;
Mora, B ;
Bardella, MT ;
Verrienti, A ;
Fiore, B ;
Uccini, S ;
Megiorni, F ;
Mazzilli, MC ;
Tiberti, C .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 42 (02) :150-154
[5]   Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study [J].
Card, TR ;
West, J ;
Holmes, GKT .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (07) :769-775
[6]   The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects [J].
Catassi, C ;
Fabiani, E ;
Ratsch, IM ;
Coppa, GV ;
Giorgi, PL ;
Pierdomenico, R ;
Alessandrini, S ;
Iwanejko, G ;
Domenici, R ;
Mei, E ;
Miano, A ;
Marani, M ;
Bottaro, G ;
Spina, M ;
Dotti, M ;
Montanelli, A ;
Barbato, M ;
Viola, F ;
Lazzari, R ;
Vallini, M ;
Guariso, G ;
Plebani, M ;
Cataldo, F ;
Traverso, G ;
Ughi, C ;
Chiaravalloti, G ;
Baldassarre, M ;
Scarcella, P ;
Bascietto, F ;
Ceglie, L ;
Valenti, A ;
Paolucci, P ;
Caradonna, M ;
Bravi, E ;
Ventura, A .
ACTA PAEDIATRICA, 1996, 85 :29-35
[7]   Risk of non-Hodgkin lymphoma in celiac disease [J].
Catassi, C ;
Fabiani, E ;
Corrao, G ;
Barbato, M ;
De Renzo, A ;
Carella, AM ;
Gabrielli, A ;
Leoni, P ;
Carroccio, A ;
Baldassarre, M ;
Bertolani, P ;
Caramaschi, P ;
Sozzi, M ;
Guariso, G ;
Volta, U ;
Corazza, GR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (11) :1413-1419
[8]  
Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001
[9]   Mortality and causes of death in celiac disease in a Mediterranean area [J].
Cottone, M ;
Termini, A ;
Oliva, L ;
Magliocco, A ;
Marrone, C ;
Orlando, A ;
Pinzone, F ;
Di Mitri, R ;
Rosselli, M ;
Rizzo, A ;
Pagliaro, L .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (12) :2538-2541
[10]   The clinical and biochemical syndrome in lymphadenoma and allied diseases involving the mesenteric lymph glands [J].
Fairley, NH .
BMJ-BRITISH MEDICAL JOURNAL, 1937, 1937 :375-+